Not all sufferers with CLL involve therapy. Despite all modern advancements, the iwCLL still suggests watchful observation for individuals with asymptomatic illness.86 This advice relies on at the very least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both